White Paper


White PapersLinks

Assessing RA-patient Autoantibody Response to Citrullinated Immunome Proteins

View Paper

KREX Protein Arrays for Rapid Screening of Vaccine Candidates

View Paper

Autoantibody Discovery using a Novel Microarray of Functional Proteins

View Paper

Rapid Determination of the Effect of Genetic Mutations on Protein Function

View Paper

Fully Functional Protein Microarray for Predictive Toxicology Studies

View Paper

Exploring Diverse Protein Interactions using the Sengenics Protein Array

View Paper

FEATURED PRODUCTS

IMMUNOME
Protein Array

High-throughput
sero-profiling platform

CTA
Protein Array

Screening of
cancer-testis antigens

OncoREX p53
Cancer Array

Cancer drug
screening and discovery

Custom
Protein Array

Flexible format for
high-throughput screening

Sengenics is a functional proteomics company that leverages its patented KREX technology for production of full-length, correctly folded and functional proteins. The key application of KREX is the discovery of autoantibody biomarkers for two core medical use cases:  stratification of patients undergoing treatment with autoimmune or cancer drugs and identification of autoantibody biomarkers that may be used to diagnose cancer, autoimmune or neurodegenerative conditions. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Find Us On:

2008 – 2019 © Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361 

2008 – 2019 © Sengenics All rights reserved 

X